2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
54
Neoplasms
38
Lung Neoplasms
25
Colorectal Neoplasms
24
Prostatic Neoplasms
17
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Pancreatic Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Hematologic Neoplasms
9
Anxiety Disorders
9
Urinary Bladder Neoplasms
8
Obesity
8
Melanoma
8
Lymphoma
8
Depression
8
Ovarian Neoplasms
7
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Sarcoma
5
Papillomavirus Infections
5
Pain
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Interventions
Bupivacaine
11
Ketamine
9
Ropivacaine
8
Morphine
8
Analgesics, Opioid
8
Acetaminophen
8
Fentanyl
7
Dexmedetomidine
7
Lidocaine
6
Anesthesia, General
6
Saline Solution
5
Anesthesia, Local
5
Acupuncture Therapy
5
parecoxib
4
Tramadol
4
Surveys and Questionnaires
4
Sodium Chloride
4
Pregabalin
4
Ethanol
4
Analgesia, Epidural
4
Transcutaneous Electric Nerve Stimulation
3
Radiofrequency Ablation
3
Propofol
3
Oxycodone
3
Ketorolac
3
Control Groups
3
Anesthetics, Local
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
Therapeutics
2
Tea
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Methods
×
Clear all
NCT07332377
2026-03-18
PsyMINT
Virginia Commonwealth University
Phase NA
Recruiting
25 enrolled